Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Singh Shawn Create: Alert

All | News | Filings
Date FiledTypeDescription
07/05/2023 4 Singh Shawn (CEO) has filed a Form 4 on Vistagen Therapeutics, Inc.
Txns: Granted 167 shares @ $1.5895, valued at $265.4
01/03/2023 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 5,000 shares @ $0.0876, valued at $438
08/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2022 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 3,623 shares @ $1.6575, valued at $6k
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2020 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 300,000 options to buy @ $0.398, valued at $119.4k
10/22/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/28/2019 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 80,000 options to buy @ $1, valued at $80k
Granted 170,000 options to buy @ $1, valued at $170k
01/15/2019 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Exercised 21,250 options to buy @ $1.5, valued at $31.9k
Exercised 1,125 options to buy @ $1.5, valued at $1.7k
Exercised 3,000 options to buy @ $1.5, valued at $4.5k
01/14/2019 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 220,000 options to buy @ $1.7, valued at $374k
08/31/2018 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Disposed/sold 3,000 options to buy @ $10, valued at $30k
Granted 3,000 options to buy @ $1.5, valued at $4.5k
Disposed/sold 1,125 options to buy @ $10, valued at $11.3k
Granted 1,125 options to buy @ $1.5, valued at $1.7k
Disposed/sold 50,000 options to buy @ $10, valued at $500k
Granted 50,000 options to buy @ $1.5, valued at $75k
Disposed/sold 21,250 options to buy @ $10, valued at $212.5k
Granted 21,250 options to buy @ $1.5, valued at $31.9k
Disposed/sold 5,000 options to buy @ $10, valued at $50k
Granted 5,000 options to buy @ $1.5, valued at $7.5k
Disposed/sold 200,000 options to buy @ $3.49, valued at $698k
02/05/2018 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 300,000 options to buy @ $1.16, valued at $348k
09/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/28/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
11/10/2016 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $3.8, valued at $380k
06/21/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
02/16/2016 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 5,625 shares @ $0
Disposed/sold 2,500 warrants @ $10, valued at $25k
Disposed/sold 5,000 warrants @ $20, valued at $100k
11/13/2015 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Disposed/sold 4,017 options to buy @ $10, valued at $40.2k
Granted 4,017 options to buy @ $7, valued at $28.1k
Disposed/sold 1,786 options to buy @ $10, valued at $17.9k
Granted 1,786 options to buy @ $7, valued at $12.5k
Disposed/sold 72,000 options to buy @ $12.8, valued at $921.6k
Granted 72,000 warrants @ $7, valued at $504k
Disposed/sold 150,000 options to buy @ $10, valued at $1.5M
Granted 150,000 options to buy @ $7, valued at $1.1M
Disposed/sold 250,000 options to buy @ $9.25, valued at $2.3M
Granted 250,000 options to buy @ $7, valued at $1.8M
09/03/2015 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 250,000 warrants @ $9.25, valued at $2.3M
01/13/2015 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 150,000 options to buy @ $10, valued at $1.5M
12/24/2013 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 100,000 shares @ $0
Disposed/sold 60,000 options to buy @ $1.13, valued at $67.8k
Granted 60,000 options to buy @ $0.5, valued at $30k
Disposed/sold 22,500 options to buy @ $1.13, valued at $25.4k
Granted 22,500 options to buy @ $0.5, valued at $11.3k
Disposed/sold 1,000,000 options to buy @ $1.5, valued at $1.5M
Granted 1,000,000 options to buy @ $0.5, valued at $500k
Disposed/sold 425,000 options to buy @ $1.5, valued at $637.5k
Granted 425,000 options to buy @ $0.5, valued at $212.5k
Disposed/sold 100,000 options to buy @ $1.75, valued at $175k
Granted 100,000 options to buy @ $0.5, valued at $50k
10/15/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
06/27/2013 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Exercised 50,000 shares @ $0.64, valued at $32k
Exercised 50,000 warrants @ $0.64, valued at $32k
03/05/2013 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Acquired 1,500,000 warrants @ $0.64, valued at $960k
12/06/2012 4 Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 100,000 shares @ $0.5, valued at $50k
Granted 50,000 warrants @ $1.5, valued at $75k
07/27/2011 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
05/25/2011 4 Form 4 - Statement of changes in beneficial ownership of securities
05/25/2011 3 Singh Shawn (CEO) has filed a Form 3 on Excaliber Enterprises, Ltd.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy